Monday, December 31, 2018

Lupin gets USFDA nod for Clobazam Oral Suspension

Lupin gets USFDA nod for Clobazam Oral Suspension The drug is indicated for treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients of two years of age or older.

from Moneycontrol Business News http://bit.ly/2SzDNZX

No comments:

Post a Comment

Network18 Q4 loss at Rs 29.61 crore, revenue up 9.7% to Rs 615.78 cr

Network18 Media & Investments reported a consolidated net loss of Rs 29.61 crore for the March quarter, despite a 9.7% rise in operation...